10 Favorite Defensive Stocks of Hedge Funds
In this article, we discuss the 10 defensive stocks that are considered as favorites among hedge funds.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 4,360,199 | $318,425 | -35% | 0.84% |
| 2. | 4,034,200 | $294,617 | +220% | 0.06% | |
| 3. | Pzena Investment Management Richard S. Pzena | 3,625,787 | $264,791 | +214% | 1% |
| 4. | 3,333,100 | $243,417 | -7% | 0.05% | |
| 5. | Renaissance Technologies Jim Simons | 2,633,332 | $192,312 | -48% | 0.22% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $54.50 | 9,174 | Director | 22,109 | 2020-06-15 | Filing | |
| $58.90 | 88 | Director | 7,189 | 2019-12-04 | Filing | |
| $44.72 | 11,000 | Director | 11,397 | 2019-07-31 | Filing | |
| $47.29 | 5,000 | Director | 27,000 | 2019-05-16 | Filing | |
| $52.40 | 9,540 | Director | 12,935 | 2018-04-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $74.04 | 30,000 | Officer, Director | 551,104 | 2022-06-13 | Filing | |
| $74.89 | 65,000 | Officer | 308,627 | 2022-06-06 | Filing | |
| $71.52 | 25,000 | Officer, Director | 581,524 | 2022-03-21 | Filing | |
| $69.23 | 43,228 | Officer | 50,385 | 2022-03-16 | Filing | |
| $69.27 | 31,331 | Officer | 46,308 | 2022-03-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,601,833 | $701,221,866 | 0.3% | |
| 2. | 3,812,273 | $278,410,297 | 0.37% | |
| 3. | 12,113 | $88,461,239 | 0.11% | |
| 4. | 642,402 | $46,914,618 | 0.27% | |
| 5. | 270,300 | $19,740,009 | 0.16% |
News See All
10 Best Stocks to Buy According to Billionaire Chris Rokos
In this article, we discuss the 10 best stocks to buy according to billionaire Chris Rokos.
11 Best Bear Market Stocks To Invest In
In this article, we discuss the 11 best bear market stocks to invest in.
15 Best Drug Stocks To Buy Now
The pharmaceutical industry is thriving globally, and it was given a healthy boost by the COVID-19 vaccine rollouts around the world.
10 Best Healthcare Stocks to Buy in 2022 According to Hedge Funds
In this article, we discuss the 10 best healthcare stocks to buy in 2022 according to hedge funds.
5 Recession-Proof Dividend Stocks to Buy
In this article, we discuss 5 recession-proof dividend stocks to buy.
10 Stocks to Buy When Everyone is Selling
In this article, we discuss the 10 stocks to buy when everyone is selling.
Warren Buffett is Selling These 3 Stocks in 2022
Royalty Pharma plc (NASDAQ:RPRX) is a New York-based firm that buys biopharmaceutical royalties and funds innovations in the biopharmaceutical industry in the United States.
Michael Burry’s 2022 Portfolio: Top 5 Stock Picks
In this article, we discuss top 5 stock picks of Michael Burry's 2022 portfolio.
Living Off Dividends in Retirement: 10 Best Stocks To Consider
The average age of retirement in the United States is 62, and American retirees represent a significant proportion of the adult populace.
Billionaire Hedge Funds
